The National Coordinating Council for Medication Error Reporting and Prevention defines a medication error as "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer". The council, a group of more than 25 national and international organizations, including the FDA, examines and evaluates medication errors and recommends strategies for error prevention.
Medication Processes are complex in nature, involving multiple interactions, and are high risk activities. Although errors occur at every stage of the preparation and distribution process, one third of those that harm the patients are attributed to the administration phase. Most medication administrators are nurses, and therefore when errors occur, nurses are often deemed accountable. Medication administrators can provide a safeguard against errors made by prescribers or pharmacists. Therefore, nurses provide a safety defense against medication errors but at the same time, have the potential to place patients at risk. Communicating with and educating patients about their medications during the administration process can result in individuals being better informed about and more involved with their medications.
Higher medication error rates are associated with greater levels of interruption. The most common source of interruption is from another nurse requiring face-to-face communication. Such interruptions frequently occur during direct patient care activities, and the activity interrupted most often is that of medication administration. Other sources of interruption include patients, technical sources and operational failure. Any intervention that leads to fewer distractions could ultimately enable nurses to focus more on the task that they are preforming and create less workrelated stress and greater job satisfaction.
A safe reporting environment that encourages staff engagement to identify contributory factors as well as possible solutions must also be fostered. Extensive organizational resources are required to enhance communication, to reduce confusion, to improve knowledge, skill and compliance with policies and guidelines.
Regulatory approach
The public took notice in 1999 when the Institute of medicine (IOM) released a report that between 44,000 and 98,000 deaths may result each year from medical errors in hospitals alone, and more that 7,000 deaths each year are related to medications. In response to the IOM's report, all parts of the U.S health system put error medication strategies into high-gear by re-evaluating and strengthening checks and balances to prevent errors.
In addition, the U. The FDA enhanced its efforts to reduce medication errors by dedicating more resources to drug safety, which included forming a new division on medication errors at the agency in 2002.
Patient Safety Proposals
In March 2003, the Department of Health and Human Services announced two new FDA strategies that will use stateof-the-art technology to improve patient safety.  Bar codes: Just as the technology is used in retail and other industries, required bar codes would contain unique identifying information about drugs. When used with bar code scanners and computerized patient information systems, bar code technology can prevent many medication errors, including administering the wrong drug or dose, or administering a drug to a patient with a known allergy. The requirement took effect in April 2004.  Safety reporting: A proposed revamping of safety reporting requirements aims to enhance the FDA's ability to monitor and improve the safe use of drugs and biologics.
Who Tracks Medication Errors?
The Food and Drug Administration Accepts reports from consumers and health professionals about products regulated by the FDA, including drugs and medical devices, through MedWatch, the FDA's safety information and adverse event reporting program.
(800) 332-1088 www.fda.gov/medwatch.htm
